AGI Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch AGI Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) (NCT00552565) | AGI Therapeutics, Inc. | 2007-09-01 |
Track AGI Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.